Shareprice
06 Nov 2025

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

FluoGuide convenes an extraordinary general meeting

Regulatory


November 5, 2025

Copenhagen, Denmark 4 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby invites shareholders to participate in an extraordinary general meeting to be held on 24 November at 10 AM CET at the Company’s premises.

To the shareholders of FluoGuide A/S

Following the issuance of shares resolved by the Board of Directors on 3 November 2025, the board of directors proposes to reestablish the authorisation to issue up to nominal DKK 300,000 corresponding to 3,000,000 shares of nominal DKK 0.1 each.

The board of directors proposes to elect Camilla Harder Hartvig. Camilla Harder Hartvig’s bio is attached as appendix 1. Donna Haire has informed the board of directors that she has resigned as of 24 November 2025 as she has taken up a position as Chief Operating Officer in FluoGuide.

The extraordinary general meeting will be held on:
24 November 2025 at 10 AM CET
 
at the Company’s premises, Titanhus, Titangade 13B, 2200 Copenhagen.

Please find the convening notice attached to this press release. The convening notice can also be found on the Company’s website: www.fluoguide.com/investor/general-meeting/